A novel p53 mutational hotspot in skin tumors from UV-irradiated Xpc mutant mice alters transactivation functions
- 13 August 2002
- journal article
- Published by Springer Nature in Oncogene
- Vol. 21 (37) , 5704-5715
- https://doi.org/10.1038/sj.onc.1205779
Abstract
A mutation in codon 122 of the mouse p53 gene resulting in a T to L amino acid substitution (T122-->L) is frequently associated with skin cancer in UV-irradiated mice that are both homozygous mutant for the nucleotide excision repair (NER) gene Xpc (Xpc(-/-)) and hemizygous mutant for the p53 gene. We investigated the functional consequences of the mouse T122-->L mutation when expressed either in mammalian cells or in the yeast Saccharomyces cerevisiae. Similar to a non-functional allele, high expression of the T122-->L allele in p53(-/-) mouse embryo fibroblasts and human Saos-2 cells failed to suppress growth. However, the T122-->L mutant p53 showed wild-type transactivation levels with Bax and MDM2 promoters when expressed in either cell type and retained transactivation of the p21 and the c-Fos promoters in one cell line. Using a recently developed rheostatable p53 induction system in yeast we assessed the T122-->L transactivation capacity at low levels of protein expression using 12 different p53 response elements (REs). Compared to wild-type p53 the T122-->L protein manifested an unusual transactivation pattern comprising reduced and enhanced activity with specific REs. The high incidence of the T122-->L mutant allele in the Xpc(-/-) background suggests that both genetic and epigenetic conditions may facilitate the emergence of particular functional p53 mutations. Furthermore, the approach that we have taken also provides for the dissection of functions that may be retained in many p53 tumor alleles.Keywords
This publication has 57 references indexed in Scilit:
- p53 mutants can often transactivate promoters containing a p21 but not Bax or PIG3 responsive elementsOncogene, 2001
- Kinetics of p53 Binding to Promoter Sites In VivoMolecular and Cellular Biology, 2001
- The Tumor Suppressor Protein p53 Requires a Cofactor to Activate Transcriptionally the Human BAX PromoterJournal of Biological Chemistry, 2001
- p53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assayOncogene, 2001
- Age-dependent spontaneous mutagenesis in Xpc mice defective in nucleotide excision repairOncogene, 2000
- Activation of the insulin-like growth factor II transcription by aflatoxin B1 induced p53 mutant 249 is caused by activation of transcription complexes; implications for a gain-of-function during the formation of hepatocellular carcinomaOncogene, 2000
- Procaspase 3/p21 complex formation to resist Fas-mediated cell death is initiated as a result of the phosphorylation of p21 by protein kinase ACell Death & Differentiation, 2000
- Novel p53 mutants selected in BRCA-associated tumours which dissociate transformation suppression from other wild-type p53 functionsOncogene, 1999
- Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeastOncogene, 1998
- Somatic mutation theory, DNA repair rates, and the molecular epidemiology of p53 mutationsMutation Research - Fundamental and Molecular Mechanisms of Mutagenesis, 1997